First-ever vaccine for disfiguring skin disease to begin testing in humans | ChicagoLIVE
First-ever vaccine for disfiguring skin disease to begin testing in humans | ChicagoLIVE

First-ever vaccine for disfiguring skin disease to begin testing in humans | ChicagoLIVE

A vaccine for leishmaniasis years in the making has been developed and approved for testing in humans, with clinical trials set to begin in a few months. Dr. Abhay Satoskar from The Ohio State University Wexner Medical Center joins ChicagoLIVE to talk about what the disease is and the testing process for the vaccine. 

Chicago Area News

Good Day Chicago

FOX 32 Sports